Unique Pharmaceutical Laboratories
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Plot No. 4, Phase IV, G.I.D.C Industrial Estate, Bharuch, GJ 394116, India (IND)
- Operations here
- analysismanufacture
- FDA identifiers
- FEI 3013151303 · DUNS 864354608
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2025-03-07
- VAIDrug Quality Assurance2018-12-08
Drugs this plant is listed as making
5 distinct drugs across 18 products name this site in their FDA label.
- AtenololRising Pharma Holdings, Inc.
- ciprofloxacinRising Pharma Holdings, Inc.
- Diclofenac SodiumRising Pharma Holdings, Inc.
- Enalapril MaleateRising Pharma Holdings, Inc.
- GlipizideRising Pharma Holdings, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.